Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial on Chemosensitivity Testing in Advanced Primary Ovarian Carcinoma (Phase III)

NCT00003214 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT00003214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial on Chemosensitivity Testing in Advanced Primary Ovarian Carcinoma (Phase III)
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1996
Completion date
April 30, 2000
Enrollment
300 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer